BRAIN.Q

About

BRAIN.Q is a healthtech company focused on AI-powered neuromodulation and a connected virtual care platform aimed at restoring brain function and enhancing recovery, particularly for ischemic stroke patients. The company develops noninvasive therapies that utilize low-intensity, low-frequency electromagnetic stimulation, tailored by AI to optimize brain learning and improve recovery outcomes. The flagship product, the Q Therapeutic System, delivers frequency-tuned electromagnetic field therapy through a home-based device designed for neurorehabilitation. This AI-driven solution enhances brain plasticity and aims to restore motor function after a stroke. BRAIN.Q has received FDA Breakthrough Device Designation and CE Mark, and is involved in pivotal clinical trials. Additionally, the company offers a virtual care platform to support ongoing neurorecovery and is expanding its network with concierge and neuro-rehab clinics for at-home therapy delivery. BRAIN.Q has achieved significant recognition, including funding for its therapies and awards for innovation in technology. The leadership team includes experienced professionals with backgrounds in health and technology, driving the company's mission to address various neurological conditions.